Vivo Capital, LLC Verona Pharma PLC Transaction History
Vivo Capital, LLC
- $748 Million
- Q1 2024
A detailed history of Vivo Capital, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Vivo Capital, LLC holds 3,610,177 shares of VRNA stock, worth $52.2 Million. This represents 7.77% of its overall portfolio holdings.
Number of Shares
3,610,177
Previous 4,249,918
15.05%
Holding current value
$52.2 Million
Previous $84.5 Million
31.25%
% of portfolio
7.77%
Previous 10.37%
Shares
7 transactions
Others Institutions Holding VRNA
# of Institutions
115Shares Held
60.7MCall Options Held
139KPut Options Held
67.8K-
Nea Management Company, LLC Timonium, MD5.11MShares$73.9 Million5.77% of portfolio
-
Wellington Management Group LLP Boston, MA3.91MShares$56.5 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY3.76MShares$54.4 Million1.27% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.4MShares$49.1 Million1.23% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.19MShares$46.1 Million1.69% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $881M
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...